Background: Many ambulatory sleep apnea monitoring devices are equipped with software which allows an automated analysis of data as well as a visual analysis. Objective: The Merlin system which records heart rate, snoring sound, efforts, oronasal flow, body position and oxygen saturation was investigated to identify proper parameter settings for the automated analysis and to compare the automated with the visual analysis in patients with mild obstructive sleep apnea syndrome (OSAS). Sensitivity and specificity of the visual and automated analysis of ambulatory monitoring in comparison with visual polysomnographic (PSG) analysis were determined. Methods and Results: First, we tried to find the optimal parameters for the automated analysis, using 7 different settings in 17 OSAS patients. Furthermore, we applied the optimized setting to 66 OSAS patients who were admitted (age 50.9 ± 9.9 years, BMI 32.9 ± 5 kg/m2), and compared the results with the visual analysis of raw data. The patients slept for one night in the sleep laboratory with Merlin and PSG simultaneously to compare the visual and automated analysis of Merlin data with results from the visual analysis of PSG. Automated analysis leads to an underestimation of the respiratory disturbance index (RDI; p < 0.001) compared with both the visual analysis and results of PSG. Using a cutoff level of 5 apneas and hypopneas/h for the diagnosis of OSAS, the sensitivity of Merlin with the automated analysis is 40.6% and the specificity is 100%. With a cutoff level of 15/h, sensitivity and specificity rose to 91.3 and 100%, respectively, which is comparable to the visual analysis. Conclusion: Merlin is a reliable device for detection of sleep-related breathing disorders, but recordings should be analyzed visually, especially in patients with a low RDI.

Keywords:
Sleep apnea, Ambulatory monitoring, Merlin system, Polysomnography
1.
Peter JH, Becker H, Cassel W, Faust M, Ploch T, Riess M, Penzel T: Diagnosis of sleep apnea: Initial experiences with a staged procedure. Pneumologie 1989;43:587–590.
2.
Kayed K: The present state of ambulatory monitoring of sleep; in Peter JH, Penzel T, Podszus T, von Wichert P (eds): Sleep and Health Risk. Berlin, Springer, 1991, pp 3–10.
3.
Man G, Kang B: Validation of a portable sleep apnea monitoring device. Chest 1995;108:388–393.
4.
Orr WC, Eiken T, Pegram V, Jones R, Rundell OH: A laboratory validation study of a portable system for remote recording of sleep-related breathing disorders. Chest 1994;105:160–162.
5.
Roos M, Althaus W, Rhiel C, Penzel T, Peter JH, von Wichert P: Comparative use of MESAM IV and polysomnography in sleep-related respiratory disorders. Pneumologie 1993;47:112–118.
6.
Stoohs R, Guilleminault C: Investigations of an automated screening device (MESAM) for obstructive sleep apnea. Eur Respir J 1990;3:823–829.
7.
van Surell C, Lemaigre D, Leroy M, Foucher A, Hagenmuller MP, Raffestin B: Evaluation of an ambulatory device, CID 102, in the diagnosis of obstructive sleep apnea syndrome. Eur Respir J 1995;8:795–800.
8.
Verse T, Pirsig W, Junge-Hulsing B, Kroker B: Validation of the POLY-MESAM seven-channel ambulatory recording unit. Chest 2000;117:1613–1618.
9.
White DP, Gibb TJ, Wall JM, Westbrook PR: Assessment of accuracy and analysis time of a novel device to monitor sleep and breathing in the home. Sleep 1995;18/2:115–126.
10.
Whittle AT, Finch SP, Mortimore IL, MacKay TW, Douglas NJ: Use of home sleep studies for diagnosis of the sleep apnea/hypopnea syndrome. Thorax 1997;52:1068–1073.
11.
Wildschiodtz GH, Clausen J, Langemark M: The somnolog system: Home monitoring of sleep-EEG, other physiological data, and sound pressure level; in Miles LE, Broughton RJ (eds): Medical Monitoring in the Home and Work Environment. New York, Raven Press, 1990, pp 285–294.
12.
American Academy of Sleep Medicine Task Force Report: Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667–689.
13.
Redline S, Kapur VK, Sanders MH, Quan SF, Gottlieb DJ, Rapoport DM, Bonekat WH, Smith PL, Kiley JP, Iber C: Effects of varying approaches for identifying respiratory disturbances on sleep apnea assessment. Am J Respir Crit Care Med 2000;161:369–374.
14.
White DP, Gibb TJ: Evaluation of a computerized polysomnographic system. Sleep 1998;21/2:188–196.
15.
Bliwise D, Benkert R, Ingham R: Factors associated with nightly variability in sleep disordered breathing in the elderly. Chest 1991;100:973–976.
16.
Wittig RM, Pomaker A, Zorick FJ, Roehrs TA, Conway WA, Roth T: Night-to-night consistency of apneas during sleep. Am Rev Respir Dis 1984;129/2:244–246.
17.
Rechtschaffen A, Kales A: A Manual of Standardized Terminology: Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, UCLA Brain Information Service/Brain Research Institute, 1968.
18.
Berg S, Haight JS, Yap V, Hoffstein V, Cole P: Comparison of direct and indirect measurements of respiratory airflow: Implications for hypopneas. Sleep 1997;20/1:60–64.
19.
Broughton R, Fleming J, Fleetham J: Home assessment of sleep disorders by portable monitoring. J Clin Neurophysiol 1996;13/4:272–284.
20.
Schafer H, Ewig S, Hasper E, Luderitz B: Predictive diagnostic value of clinical assessment and nonlaboratory monitoring system recordings in patients with symptoms suggestive of obstructive sleep apnea syndrome. Respiration 1997;64/3:194–199.
21.
Carrasco O, Montserrat JM, Lioberes P, Ascasco C, Ballester E, Fornas C, Rodriguez-Roisin R: Visual and different automatic scoring profiles of respiratory variables in the diagnosis of sleep apnoea-hypopnoea syndrome. Eur Respir J 1996;9:125–130.
22.
Kociej M, Cieslicki JK, Gorzelak K, Sliwinski P, Zielinski J: Hand-scoring of MESAM 4 recordings is more accurate than automatic analysis in screening for obstructive sleep apnea. Eur Respir J 1994;7:1771–1775.
23.
Redline S, Sanders M: Hypopnea, a floating metric: Implications for prevalence, morbidity estimates, and case finding. Sleep 1997;20:1209–1217.
24.
Whyte KF, Allen MB, Fitzpatrick MF, Douglas NJ: Accuracy and significance of scoring hypopneas. Sleep 1992;15/3:257–260.
25.
Vazquez JC, Tsai WH, Flemons WW, Masuda K, Brant R, Hajduk E, Whitelaw WA, Remmers JE: Automated analysis of digital oximetry in the diagnosis of obstructive sleep apnoea. Thorax 2000;55:302–307.
26.
Sergi M, Rizzi M, Greco M, Andreoli A, Bamberga M, Castonovo C, Ferini-Strambi L: Validity of diurnal sleep recording performed by an ambulatory device in the diagnosis of obstructive sleep apnea. Respir Med 1998;92:216–220.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.